Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$55.75 - $92.75 $1.79 Million - $2.97 Million
-32,038 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$37.9 - $104.44 $26,151 - $72,063
-690 Reduced 2.11%
32,038 $2.59 Million
Q4 2019

Jan 14, 2020

BUY
$77.66 - $99.74 $2.54 Million - $3.26 Million
32,728 New
32,728 $3.03 Million
Q3 2019

Nov 13, 2019

SELL
$90.37 - $122.49 $14.4 Million - $19.5 Million
-158,992 Closed
0 $0
Q2 2019

Aug 16, 2019

SELL
$89.51 - $118.04 $2.79 Million - $3.67 Million
-31,132 Reduced 16.37%
158,992 $18.8 Million
Q1 2019

May 13, 2019

SELL
$61.98 - $96.5 $3.88 Million - $6.04 Million
-62,627 Reduced 24.78%
190,124 $16.5 Million
Q4 2018

Feb 13, 2019

SELL
$56.04 - $82.66 $1 Million - $1.48 Million
-17,860 Reduced 6.6%
252,751 $15.9 Million
Q3 2018

Nov 13, 2018

BUY
$48.29 - $80.6 $810,885 - $1.35 Million
16,792 Added 6.62%
270,611 $21.4 Million
Q2 2018

Sep 27, 2018

BUY
$37.84 - $69.96 $4.34 Million - $8.03 Million
114,713 Added 82.46%
253,819 $15.2 Million
Q2 2018

Aug 10, 2018

SELL
$37.84 - $69.96 $2.78 Million - $5.15 Million
-73,568 Reduced 34.59%
139,106 $2.49 Million
Q1 2018

May 14, 2018

BUY
$39.82 - $57.53 $2.84 Million - $4.1 Million
71,327 Added 50.46%
212,674 $8.58 Million
Q4 2017

Feb 14, 2018

SELL
$46.49 - $60.51 $4.42 Million - $5.75 Million
-95,083 Reduced 40.22%
141,347 $7.43 Million
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $8.76 Million - $11.1 Million
236,430
236,430 $11.1 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.